Literature DB >> 36148201

Combined Tricuspid Valve Repair and Orthotopic Liver Transplantation in a Patient With Severe Tricuspid Regurgitation and Pulmonary Hypertension.

Nimit Kasliwal1, Cheng Yang2, Eric J Martinez3, Robert F Hebeler3, Saravanan Ramamoorthy4,5.   

Abstract

Severe pulmonary hypertension and severe tricuspid regurgitation are often considered strict contraindications for orthotopic liver transplantation. A combined approach of tricuspid repair and subsequent liver transplantation could provide a novel approach for patients with severe pulmonary hypertension and tricuspid regurgitation to undergo orthotopic liver transplantation. A 62-year-old male with a history of end-stage renal disease on hemodialysis, cirrhosis, and third-degree atrioventricular heart block status post single lead pacemaker insertion presented for an orthotopic liver transplant. However, after placement of a Swan-Ganz catheter by the anesthesia team, the patient's central venous pressure was found to be high, and his mean pulmonary artery pressure was 40 mmHg. His case was canceled due to concern for poor postoperative outcomes after a subsequent transesophageal echocardiogram revealed a severely dilated right heart and 4+ tricuspid regurgitation with flow reversal into the hepatic veins. After discussion among the hospital's transplant committee, the patient was planned to have a tricuspid valve repair, liver transplant, and kidney transplant surgery several months later. The patient successfully underwent tricuspid valve repair and orthotopic liver transplant and then kidney transplant the following day.
Copyright © 2022, Kasliwal et al.

Entities:  

Keywords:  cirrhosis; end-stage renal disease; orthotopic liver transplantation; third degree atrioventricular block; tricuspid valve regurgitation; tricuspid valve repair

Year:  2022        PMID: 36148201      PMCID: PMC9482466          DOI: 10.7759/cureus.28146

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  8 in total

Review 1.  Anesthesia for Liver Transplantation.

Authors:  Dieter Adelmann; Kate Kronish; Michael A Ramsay
Journal:  Anesthesiol Clin       Date:  2017-07-10

Review 2.  The Myths and Realities of Portopulmonary Hypertension.

Authors:  Hilary M DuBrock; Michael J Krowka
Journal:  Hepatology       Date:  2020-10       Impact factor: 17.425

3.  MELD exceptions for portopulmonary hypertension: current policy and future implementation.

Authors:  D S Goldberg; S Batra; S Sahay; S M Kawut; M B Fallon
Journal:  Am J Transplant       Date:  2014-07-01       Impact factor: 8.086

4.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation.

Authors:  Kelley Weinfurtner; Kimberly Forde
Journal:  Curr Hepatol Rep       Date:  2020-07-11

5.  Role of pretransplant echocardiographic evaluation in predicting outcomes following liver transplantation.

Authors:  L Kia; S J Shah; E Wang; D Sharma; S Selvaraj; C Medina; J Cahan; H Mahon; J Levitsky
Journal:  Am J Transplant       Date:  2013-08-05       Impact factor: 8.086

6.  Portopulmonary hypertension in the current era of pulmonary hypertension management.

Authors:  Laurent Savale; Manuel Guimas; Nathan Ebstein; Marie Fertin; Mitja Jevnikar; Sébastien Renard; Delphine Horeau-Langlard; Cécile Tromeur; Céline Chabanne; Grégoire Prevot; Ari Chaouat; Pamela Moceri; Élise Artaud-Macari; Bruno Degano; Romain Tresorier; Clément Boissin; Hélène Bouvaist; Anne-Claire Simon; Marianne Riou; Nicolas Favrolt; Sylvain Palat; Delphine Bourlier; Pascal Magro; Vincent Cottin; Emmanuel Bergot; Nicolas Lamblin; Xavier Jaïs; Audrey Coilly; François Durand; Claire Francoz; Filomena Conti; Philippe Hervé; Gérald Simonneau; David Montani; Jean-Charles Duclos-Vallée; Didier Samuel; Marc Humbert; Pascal De Groote; Olivier Sitbon
Journal:  J Hepatol       Date:  2020-03-05       Impact factor: 25.083

7.  Intraoperative TOE guided management of newly diagnosed severe tricuspid regurgitation and pulmonary hypertension during orthotopic liver transplantation: a case report demonstrating the importance of reversibility as a favorable prognostic factor.

Authors:  B Pearce; R Hu; F Desmond; D Banyasz; R Jones; C O Tan
Journal:  BMC Anesthesiol       Date:  2019-07-13       Impact factor: 2.217

8.  A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation.

Authors:  Yosuke Saragai; Akinobu Takaki; Yuzo Umeda; Takashi Matsusaki; Tetsuya Yasunaka; Atsushi Oyama; Ryuji Kaku; Kazufumi Nakamura; Ryuichi Yoshida; Daisuke Nobuoka; Takashi Kuise; Kosei Takagi; Takuya Adachi; Nozomu Wada; Yasuto Takeuchi; Kazuko Koike; Fusao Ikeda; Hideki Onishi; Hidenori Shiraha; Shinichiro Nakamura; Hiroshi Morimatsu; Hiroshi Ito; Toshiyoshi Fujiwara; Takahito Yagi; Hiroyuki Okada
Journal:  BMC Gastroenterol       Date:  2018-05-15       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.